Stanford Advisors

All Publications

  • A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study eClinicalMedicine Deng, K., Wang, L., Liu, Y., Li, X., Hou, Q., Cao, M., Ng, N. N., Wang, H., Chen, H., Yeom, K. W., Zhao, M., Wu, N., Gao, P., Shi, J., Liu, Z., Li, W., Tian, J., Song, J. 2022; 51: 1-14